Early Initiation of Therapy for RRMS
The rationale for early treatment initiation for patients with relapsing-remitting multiple sclerosis.
Appropriate Diagnosis and Management of RRMS
The patient symptoms that help neurologists distinguish relapsing and remitting multiple sclerosis from other forms of the disease, and recommendations regarding the best timing to initiate therapy.
This Week on NeurologyLive® — November 22, 2021
Here's what is coming soon to NeurologyLive®.
AMX0035 Shows Safety in Alzheimer Disease, Outcomes of Urgent Prevention in TIA, FDA Grants IDE to NeuroPace's RNS System
Neurology News Network for the week ending November 20, 2021.
NeurologyLive® Friday 5 — November 19, 2021
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 19, 2021.
UC San Diego Health: Institutional Perspectives in Neurology, Chaired by Jennifer Graves, MD, PhD, MAS
Chaired by Jennifer Graves, MD, PhD, MAS, the presentations also feature UC San Diego Health experts Jenelle Raynowska, MD; Jennifer Yang, MD; and Anastasie Dunn-Pirio, MD. [WATCH TIME: 1 hour, 23 minutes]
This Week on NeurologyLive — November 15, 2021
Here's what is coming soon to NeurologyLive.
RBD Shows No Impact Post-DBS, Erenumab Superior to Topiramate, ADORE Phase 3 Trial Begins
Neurology News Network for the week ending November 13, 2021.
NeurologyLive Friday 5 — November 12, 2021
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 12, 2021.
This Week on NeurologyLive — November 8, 2021
Benefits of Physical Activity in PD, Neonatal Seizures Increased During Rewarming, Cluster Headache Characterized by Creaky Voice
Neurology News Network for the week ending November 6, 2021.
NeurologyLive Friday 5 — November 5, 2021
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 5, 2021.
Future Outlook of Cannabis-Derived Medications to Treat MS Symptoms
Robert Fox, MD, discussed what’s currently available in terms of cannabis-derived medications that treat symptoms of multiple sclerosis, and realistic possibility of another soon entering the market.
Momentus Progress Within the MS Space Led by AHN
Research on advanced therapies and immune systems have helped clinicians understand more about how to improve treatments for multiple sclerosis.
This Week on NeurologyLive — November 1, 2021
Ocrelizumab Safety Profile in Elders, Phase 3b CASTING Trial Results, Cannabis Information Sources for MS
Neurology News Network for the week ending October 30, 2021.
NeurologyLive Friday 5 — October 29, 2021
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 29, 2021.
This Week on NeurologyLive — October 25, 2021
Cenobamate Provides Long-Term Seizure Reduction, Nerivio's Impact in Chronic Migraine, Weekly Episodes Reduced With FT218
Neurology News Network for the week ending October 23, 2021. [WATCH TIME: 3 minutes]
NeurologyLive Friday 5 — October 22, 2021
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 22, 2021.
Cleveland Clinic: Institutional Perspectives in Neurology, Chaired by Devon Conway, MD
Chaired by Devon Conway, MD, the presentations also feature Cleveland Clinic experts Kedar Mahajan, MD, PhD; Marisa McGinley, DO; and Amy Kunchok, MD. [WATCH TIME: 1 hour, 33 minutes]
Treatment Advances in NMOSD
Dr Brian G. Weinshenker envisions the future management of neuromyelitis optica spectrum disorders based on his involvement in research programs and treatment advances occurring in neurology.
Support For Patients With NMOSD
Patients with neuromyelitis optica spectrum disorders highlight the types of resources and support that have helped them manage their neurological condition.
NMOSD Research Programs
Jacinta M. Behne, MA, of the Guthy-Jackson Charitable Foundation, reacts to the types of research programs the organization has been involved in, regarding better treatments for patients with neuromyelitis optica spectrum disorders.
This Week on NeurologyLive — October 18, 2021
Alemtuzumab Treatment Poplation Identified, Siponimod Preserves Retinal Thickness, ATA188 Shows Success in Phase 1
Neurology News Network for the week ending October 15, 2021. [WATCH TIME: 3 minutes]
NeurologyLive Friday 5 — October 15, 2021
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 15, 2021.
Treating NMOSD: What to Expect
Neuromyelitis optica patient Doug highlights the types of treatments he has received since his diagnosis and provides suggestions to patients on navigating therapy, especially during the COVID-19 pandemic.
Navigating NMOSD Infusion-Based Treatment
Kim, a patient with neuromyelitis optica, describes what it has been like receiving rituximab infusions as preventive therapy, and shares advice for others who are about to embark on a similar treatment journey.
This Week on NeurologyLive — October 11, 2021